Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

vBloc Therapy for Obese Subjects With Type 2 Diabetes- A Randomized Controlled Clinical Trial

NCT03355092 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03355092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03355092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
vBloc Therapy for Obese Subjects With Type 2 Diabetes- A Randomized Controlled Clinical Trial
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Withdrawn
Start date
February 23, 2018
Completion date
November 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type2 diabetes